GLRX5
Glutaredoxin-related protein 5, mitochondrial
Also known as: C14orf87, GLRX5_HUMAN, GRX5, PR01238
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86SX6
- Gene
- GLRX5
- Ensembl
- ENSG00000182512
- Chromosome
- 14
- Canonical length
- 157 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a mitochondrial protein, which is evolutionarily conserved. It is involved in the biogenesis of iron-sulfur clusters, which are required for normal iron homeostasis. Mutations in this gene are associated with autosomal recessive pyridoxine-refractory sideroblastic anemia. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
157 residues, UniProt reviewed canonical sequence.
>Q86SX6|GLRX5
1 MSGSLGRAAA ALLRWGRGAG GGGLWGPGVR AAGSGAGGGG SAEQLDALVK KDKVVVFLKG
61 TPEQPQCGFS NAVVQILRLH GVRDYAAYNV LDDPELRQGI KDYSNWPTIP QVYLNGEFVG
121 GCDILLQMHQ NGDLVEELKK LGIHSALLDE KKDQDSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLRX5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 183 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 183 nTPM
- bone marrow: 169 nTPM
- tongue: 158 nTPM
- heart muscle: 113 nTPM
- liver: 103 nTPM
- kidney: 83 nTPM
Single-cell type
- erythrocytes: 779 nCPM
- erythrocyte progenitors: 450 nCPM
- early spermatids: 305 nCPM
- late primary spermatocytes: 266 nCPM
- extravillous trophoblasts: 194 nCPM
- megakaryocytes: 192 nCPM
Immune cell
- plasmacytoid DC: 9.1 nTPM
- T-reg: 6.2 nTPM
- memory CD8 T-cell: 6 nTPM
- naive B-cell: 5.4 nTPM
- MAIT T-cell: 4.9 nTPM
- eosinophil: 4.8 nTPM
Brain region
- choroid plexus: 28 nTPM
- hippocampal formation: 28 nTPM
- thalamus: 28 nTPM
- hypothalamus: 26 nTPM
- cerebral cortex: 24 nTPM
- basal ganglia: 24 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLRX5.
Disease | AllUniProt
Conditions GLRX5 is implicated in, by any mechanism.
- Anemia, sideroblastic, 3, pyridoxine-refractory (SIDBA3) MIM:616860
- Spasticity, childhood-onset, with hyperglycinemia (SPAHGC) MIM:616859
Disease | GeneticClinVar
9 pathogenic / likely-pathogenic of 140 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Sideroblastic anemia 3
- Spasticity-ataxia-gait anomalies syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0.75
- gnomAD missense Z
- 0.22
- DepMap mean gene effect
- -0.43
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- [2Fe-2S] cluster assembly
- cell redox homeostasis
- hemopoiesis
- intracellular iron ion homeostasis
- iron-sulfur cluster assembly
- protein maturation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLRX5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLRX5 as an antibody target. Whether an autoantibody or antibody against GLRX5 could matter depends on whether native GLRX5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLRX5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLRX5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...